Literature DB >> 20452486

17 alpha-hydroxyprogesterone caproate vehicle, castor oil, enhances the contractile effect of oxytocin in human myometrium in pregnancy.

Michael D O'Sullivan1, Mark P Hehir, Yvonne M O'Brien, John J Morrison.   

Abstract

OBJECTIVE: The possibility exists that the vehicle for 17-alpha-hydroxyprogesterone caproate, castor oil, exerts an effect on human uterine contractility. The aim of this study was to evaluate its effects on contractility of myometrial preparations that were obtained during pregnancy. STUDY
DESIGN: Myometrial strips were suspended under isometric conditions. Contractility was induced with oxytocin. Strips were incubated in castor oil or physiologic salt solution and suspended for a further oxytocin challenge. Contractile integrals were compared between both groups.
RESULTS: Strips that were exposed to castor oil demonstrated increased contractile activity that was elicited by oxytocin (mean contractility value, 165.53%+/-17.03%; n=8; P=.004), compared with control strips (mean contractility value, 72.57%+/-7.48%; n=8; P=.003). There was a significant increase in contractile activity of the castor oil-exposed strips, compared with those that were exposed to physiologic salt solution (n=8; P<.001).
CONCLUSION: Exposure of human myometrial preparations to castor oil results in enhanced oxytocin-induced contractility. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452486     DOI: 10.1016/j.ajog.2010.03.023

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Human uterine lower segment myometrial cell and nuclear volume at term: influence of maternal age.

Authors:  Eva M Sweeney; Peter Dockery; Denis J Crankshaw; Yvonne M O'Brien; Jennifer M Walsh; John J Morrison
Journal:  J Anat       Date:  2014-09-29       Impact factor: 2.610

2.  Progesterone supplementation and the prevention of preterm birth.

Authors:  Errol R Norwitz; Aaron B Caughey
Journal:  Rev Obstet Gynecol       Date:  2011

3.  17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.

Authors:  David B Nelson; Donald D McIntire; Jeffrey McDonald; John Gard; Paula Turrichi; Kenneth J Leveno
Journal:  Am J Obstet Gynecol       Date:  2017-02-20       Impact factor: 8.661

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.